US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.91

+0.38002.17%

Post-market: 17.910.00000.00%17:38 EST

Volume:646.84K

Turnover:11.48M

Market Cap:907.54M

PE:30.86

High:18.39

Open:17.55

Low:17.25

Close:17.53

52wk High:20.33

52wk Low:7.90

Shares:50.67M

Float Shares:21.84M

Volume Ratio:1.12

T/O Rate:2.96%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.5803

EPS(LYR):-1.1550

ROE:14.03%

ROA:-5.32%

PB:3.90

PE(LYR):-15.51

Loading ...

Overview Company News Filings

BRIEF-Theravance Biopharma Q3 Operating Income USD -6.455 Million

Theravance Biopharma Q3 EPS USD 0.07

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Theravance Biopharma (TBPH) Gets a Buy from H.C. Wainwright

Theravance Biopharma Announces Phase 3 CYPRESS Study Results for Ampreloxetine Expected in Q1 2026

Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy

THOMSON REUTERS

Theravance Biopharma Presents New Data Showing YUPELRI® Reduces COPD Exacerbations and Healthcare Costs at CHEST 2025

B. Riley Initiates Theravance Biopharma at Buy With $28 Price Target

MT Newswires Live

Theravance Biopharma initiated with a Buy at B. Riley

Theravance Biopharma Inc : B. Riley Initiates Coverage With Buy Rating; Price Target $28

THOMSON REUTERS

Theravance Biopharma Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference in New York City

Theravance Biopharma Completes Enrollment in Phase 3 CYPRESS Study for Ampreloxetine in Treating Neurogenic Orthostatic Hypotension Due to MSA

Theravance Biopharma Completes Enrollment in Pivotal Phase 3 Cypress Study of Ampreloxetine in Patients With Symptomatic Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy

THOMSON REUTERS

Theravance: Topline Results Anticipated in Q1 2026 and, IF Successful, Planning for Expedited Nda Submission

THOMSON REUTERS

BRIEF-Theravance Biopharma Inc - Co And Mylan Settle With Cipla Over Yupelri Inhalation Solution - SEC Filing

Theravance Biopharma- Co, Mylan Granted Cipla License to Manufacture & Market Generic Version of Yupelri in US on/After April 23, 2039

THOMSON REUTERS

Theravance Biopharma Inc. Reaches Settlement with Cipla Over YUPELRI® Patent Dispute, Granting Future License for Generic Version

Stock Track | Theravance Biopharma Soars 5.58% on Analyst Upgrades and Bullish Ratings

Theravance Biopharma Q2 Adj. EPS $(0.08) Beats $(0.17) Estimate, Sales $26.195M Beat $22.437M Estimate

Theravance Biopharma Reports 31% Increase in Viatris Collaboration Revenue for Q2 2025; YUPELRI Net Sales Rise 22% Year-over-Year

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TBPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma","latestPrice":17.91,"timestamp":1766005200000,"preClose":17.53,"halted":0,"volume":646836,"hourTrading":{"tag":"盘后","latestPrice":17.91,"preClose":17.91,"latestTime":"17:38 EST","volume":32117,"amount":575212.226183,"timestamp":1766011080716},"delay":0,"floatShares":21844151,"shares":50672431,"eps":0.580292,"marketStatus":"Post-Mkt","change":0.38,"latestTime":"12-17 17:51:32 EST","open":17.55,"high":18.385,"low":17.25,"amount":11482890.112728,"amplitude":0.064746,"askPrice":18.18,"askSize":1500,"bidPrice":17.72,"bidSize":1862,"shortable":3,"etf":0,"ttmEps":0.580292,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1400212800000,"exchange":"NASDAQ","adjPreClose":17.53,"preHourTrading":{"tag":"盘前","latestPrice":17.71,"preClose":17.53,"latestTime":"09:00 EST","volume":595,"amount":10475.220140000001,"timestamp":1765980005002},"postHourTrading":{"tag":"盘后","latestPrice":17.91,"preClose":17.91,"latestTime":"17:38 EST","volume":32117,"amount":575212.226183,"timestamp":1766011080716},"volumeRatio":1.115297,"impliedVol":0.5451,"impliedVolPercentile":0.564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","floatShares":21844151,"roa":"-5.32%","roe":"14.03%","lyrEps":-1.154994,"volumeRatio":1.115297,"shares":50672431,"dividePrice":0,"high":18.385,"amplitude":0.064746,"preClose":17.53,"low":17.25,"week52Low":7.9,"pbRate":"3.90","psRate":"11.30","week52High":20.33,"institutionHeld":0,"latestPrice":17.91,"committee":0.107674,"eps":0.580292,"divideRate":0,"volume":646836,"delay":0,"ttmEps":0.580292,"open":17.55,"prevYearClose":9.41,"prevWeekClose":18.17,"prevMonthClose":20.3,"prevQuarterClose":14.6,"fiveDayClose":17.61,"twentyDayClose":18.49,"sixtyDayClose":14.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"TBPH","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-08-12","symbol":"TBPH","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":1.08},{"market":"US","date":"2025-05-08","symbol":"TBPH","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-02-26","symbol":"TBPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-11-12","symbol":"TBPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1764824400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TBPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TBPH","date":"2025-12-16","current":30.863772,"percent":0.933871,"low":-11.134726,"twenty":-8.797895,"median":-4.410663,"eighty":0.654518,"high":58.82119,"avg":-1.231682,"sd":14.28126,"marketCap":900449098},"quantilePoints":[{"date":"2020-12-18","current":-4.365794,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1245076428},{"date":"2020-12-24","current":-4.208751,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1200289506},{"date":"2020-12-31","current":-3.986647,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1136948003},{"date":"2021-01-08","current":-3.961969,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1129910058},{"date":"2021-01-15","current":-4.036004,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1151023892},{"date":"2021-01-22","current":-4.067412,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1159981277},{"date":"2021-01-29","current":-4.181829,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1192611748},{"date":"2021-02-05","current":-4.464507,"twenty":-8.104143,"median":-5.773576,"eighty":-4.427269,"marketCap":1273228208},{"date":"2021-02-12","current":-4.410663,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1257872692},{"date":"2021-02-19","current":-4.215481,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1202208946},{"date":"2021-02-26","current":-3.833982,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1065912143},{"date":"2021-03-05","current":-4.500359,"twenty":-8.109294,"median":-5.774844,"eighty":-4.440716,"marketCap":1251176293},{"date":"2021-03-12","current":-4.775702,"twenty":-8.109294,"median":-5.774844,"eighty":-4.454509,"marketCap":1327726411},{"date":"2021-03-19","current":-4.87751,"twenty":-8.109294,"median":-5.774844,"eighty":-4.466582,"marketCap":1356030656},{"date":"2021-03-26","current":-4.80658,"twenty":-8.104143,"median":-5.773576,"eighty":-4.479554,"marketCap":1336310980},{"date":"2021-04-01","current":-4.719785,"twenty":-8.104143,"median":-5.773576,"eighty":-4.486573,"marketCap":1312180425},{"date":"2021-04-09","current":-4.914488,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505471,"marketCap":1366311129},{"date":"2021-04-16","current":-5.09277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.507772,"marketCap":1415876592},{"date":"2021-04-23","current":-4.961404,"twenty":-8.109294,"median":-5.774844,"eighty":-4.519721,"marketCap":1379354672},{"date":"2021-04-30","current":-4.630644,"twenty":-8.109294,"median":-5.774844,"eighty":-4.543546,"marketCap":1287397694},{"date":"2021-05-07","current":-4.694319,"twenty":-8.109294,"median":-5.774844,"eighty":-4.555614,"marketCap":1289261968},{"date":"2021-05-14","current":-4.449502,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1222024508},{"date":"2021-05-21","current":-4.145262,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1138467277},{"date":"2021-05-28","current":-4.107232,"twenty":-8.109294,"median":-5.774844,"eighty":-4.54777,"marketCap":1128022623},{"date":"2021-06-04","current":-3.938475,"twenty":-8.109294,"median":-5.774844,"eighty":-4.533645,"marketCap":1081674471},{"date":"2021-06-11","current":-4.325904,"twenty":-8.109294,"median":-5.774844,"eighty":-4.513199,"marketCap":1188079383},{"date":"2021-06-18","current":-4.164277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505684,"marketCap":1143689604},{"date":"2021-06-25","current":-4.085012,"twenty":-8.109294,"median":-5.774844,"eighty":-4.486884,"marketCap":1121919864},{"date":"2021-07-02","current":-3.762924,"twenty":-8.109294,"median":-5.774844,"eighty":-4.481775,"marketCap":1033460797},{"date":"2021-07-09","current":-3.590097,"twenty":-8.109294,"median":-5.774844,"eighty":-4.472621,"marketCap":985994957},{"date":"2021-07-16","current":-3.47226,"twenty":-8.109294,"median":-5.774844,"eighty":-4.457472,"marketCap":953631884},{"date":"2021-07-23","current":-3.553436,"twenty":-8.109294,"median":-5.774844,"eighty":-4.449502,"marketCap":975926445},{"date":"2021-07-30","current":-3.398939,"twenty":-8.109294,"median":-5.774844,"eighty":-4.430832,"marketCap":933494861},{"date":"2021-08-06","current":-3.615643,"twenty":-8.109294,"median":-5.772308,"eighty":-4.424502,"marketCap":955111963},{"date":"2021-08-13","current":-3.760269,"twenty":-8.109294,"median":-5.764166,"eighty":-4.416356,"marketCap":993316441},{"date":"2021-08-20","current":-3.907676,"twenty":-8.109294,"median":-5.757271,"eighty":-4.403183,"marketCap":1032255621},{"date":"2021-08-27","current":-2.28898,"twenty":-8.109294,"median":-5.730996,"eighty":-4.390152,"marketCap":604659342},{"date":"2021-09-03","current":-2.355731,"twenty":-8.109294,"median":-5.714021,"eighty":-4.38615,"marketCap":622292178},{"date":"2021-09-10","current":-2.352949,"twenty":-8.109294,"median":-5.703573,"eighty":-4.378008,"marketCap":621557477},{"date":"2021-09-17","current":-1.977479,"twenty":-8.109294,"median":-5.688858,"eighty":-4.365944,"marketCap":522372773},{"date":"2021-09-24","current":-1.952447,"twenty":-8.074271,"median":-5.669407,"eighty":-4.356033,"marketCap":515760460},{"date":"2021-10-01","current":-2.069261,"twenty":-8.045944,"median":-5.638655,"eighty":-4.341342,"marketCap":546617923},{"date":"2021-10-08","current":-2.280637,"twenty":-8.016163,"median":-5.625476,"eighty":-4.330717,"marketCap":602455238},{"date":"2021-10-15","current":-2.22223,"twenty":-7.997331,"median":-5.608563,"eighty":-4.307524,"marketCap":587026506},{"date":"2021-10-22","current":-2.147136,"twenty":-7.997331,"median":-5.5825,"eighty":-4.289657,"marketCap":567189565},{"date":"2021-10-29","current":-2.161042,"twenty":-7.997331,"median":-5.562665,"eighty":-4.280637,"marketCap":570863073},{"date":"2021-11-05","current":-2.944324,"twenty":-7.997331,"median":-5.541795,"eighty":-4.270191,"marketCap":664904866},{"date":"2021-11-12","current":-2.676073,"twenty":-7.97491,"median":-5.530125,"eighty":-4.26185,"marketCap":604326781},{"date":"2021-11-19","current":-2.728289,"twenty":-7.915096,"median":-5.521827,"eighty":-4.240905,"marketCap":616118523},{"date":"2021-11-26","current":-2.614066,"twenty":-7.915096,"median":-5.494408,"eighty":-4.224725,"marketCap":590324087},{"date":"2021-12-03","current":-2.535742,"twenty":-7.915096,"median":-5.486755,"eighty":-4.218356,"marketCap":572636474},{"date":"2021-12-10","current":-3.178652,"twenty":-7.905554,"median":-5.462928,"eighty":-4.210236,"marketCap":717822299},{"date":"2021-12-17","current":-3.508266,"twenty":-7.863621,"median":-5.43799,"eighty":-4.192263,"marketCap":792257671},{"date":"2021-12-23","current":-3.518056,"twenty":-7.79203,"median":-5.430638,"eighty":-4.183439,"marketCap":794468622},{"date":"2021-12-31","current":-3.606171,"twenty":-7.706812,"median":-5.421098,"eighty":-4.174698,"marketCap":814367187},{"date":"2022-01-07","current":-4.2295,"twenty":-7.490651,"median":-5.415781,"eighty":-4.171972,"marketCap":955131108},{"date":"2022-01-14","current":-3.224341,"twenty":-7.39119,"median":-5.403277,"eighty":-4.154162,"marketCap":728140073},{"date":"2022-01-21","current":-2.738079,"twenty":-7.283381,"median":-5.391459,"eighty":-4.143836,"marketCap":618329475},{"date":"2022-01-28","current":-2.858829,"twenty":-7.255155,"median":-5.375582,"eighty":-4.130131,"marketCap":645597878},{"date":"2022-02-04","current":-2.881673,"twenty":-7.164617,"median":-5.360998,"eighty":-4.115812,"marketCap":650756766},{"date":"2022-02-11","current":-3.005686,"twenty":-7.129748,"median":-5.345665,"eighty":-4.106391,"marketCap":678762153},{"date":"2022-02-18","current":-3.136227,"twenty":-7.086122,"median":-5.318068,"eighty":-4.092363,"marketCap":708241508},{"date":"2022-02-25","current":-3.784218,"twenty":-7.055237,"median":-5.296367,"eighty":-4.074174,"marketCap":754671493},{"date":"2022-03-04","current":-3.599506,"twenty":-6.986071,"median":-5.279742,"eighty":-4.064449,"marketCap":717835162},{"date":"2022-03-11","current":-3.704383,"twenty":-6.907174,"median":-5.270085,"eighty":-4.051495,"marketCap":738750234},{"date":"2022-03-18","current":-3.917881,"twenty":-6.883977,"median":-5.238484,"eighty":-4.041607,"marketCap":781327346},{"date":"2022-03-25","current":-3.695631,"twenty":-6.821381,"median":-5.213693,"eighty":-4.033509,"marketCap":737004982},{"date":"2022-04-01","current":-3.600481,"twenty":-6.748055,"median":-5.173949,"eighty":-4.023592,"marketCap":718029571},{"date":"2022-04-08","current":-3.707049,"twenty":-6.708949,"median":-5.154002,"eighty":-4.012509,"marketCap":739282032},{"date":"2022-04-14","current":-3.779363,"twenty":-6.646559,"median":-5.123213,"eighty":-4.006133,"marketCap":753703344},{"date":"2022-04-22","current":-3.486301,"twenty":-6.620365,"median":-5.107869,"eighty":-3.983031,"marketCap":695259077},{"date":"2022-04-29","current":-3.672795,"twenty":-6.58534,"median":-5.089808,"eighty":-3.961969,"marketCap":732450883},{"date":"2022-05-06","current":-4.869112,"twenty":-6.539981,"median":-5.065962,"eighty":-3.95749,"marketCap":709395462},{"date":"2022-05-13","current":-4.764624,"twenty":-6.488349,"median":-5.043541,"eighty":-3.95749,"marketCap":694172384},{"date":"2022-05-20","current":-4.566098,"twenty":-6.452269,"median":-5.004378,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-05-27","current":-4.827317,"twenty":-6.407665,"median":-4.988003,"eighty":-3.95749,"marketCap":703306231},{"date":"2022-06-03","current":-4.733278,"twenty":-6.37586,"median":-4.971167,"eighty":-3.95749,"marketCap":689605460},{"date":"2022-06-10","current":-4.482508,"twenty":-6.338788,"median":-4.96153,"eighty":-3.95749,"marketCap":653070071},{"date":"2022-06-17","current":-4.539976,"twenty":-6.300389,"median":-4.946484,"eighty":-3.95749,"marketCap":661442765},{"date":"2022-06-24","current":-4.696707,"twenty":-6.267019,"median":-4.910906,"eighty":-3.95749,"marketCap":684277383},{"date":"2022-07-01","current":-5.083311,"twenty":-6.240179,"median":-4.890862,"eighty":-3.95749,"marketCap":740602773},{"date":"2022-07-08","current":-4.822092,"twenty":-6.216799,"median":-4.87956,"eighty":-3.95749,"marketCap":702545077},{"date":"2022-07-15","current":-4.581771,"twenty":-6.209146,"median":-4.869112,"eighty":-3.95749,"marketCap":667531996},{"date":"2022-07-22","current":-5.062413,"twenty":-6.191017,"median":-4.862682,"eighty":-3.95749,"marketCap":737558158},{"date":"2022-07-29","current":-4.59222,"twenty":-6.179545,"median":-4.82892,"eighty":-3.95749,"marketCap":669054304},{"date":"2022-08-05","current":-6.555529,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-08-12","current":-7.237614,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":734465814},{"date":"2022-08-19","current":-7.034268,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":713830458},{"date":"2022-08-26","current":-6.815859,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":691666558},{"date":"2022-09-02","current":-7.056862,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":716123276},{"date":"2022-09-09","current":-6.906235,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":700837827},{"date":"2022-09-16","current":-7.584055,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":769622347},{"date":"2022-09-23","current":-7.523805,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":763508167},{"date":"2022-09-30","current":-6.731347,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":683090347},{"date":"2022-10-07","current":-6.578663,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":667596187},{"date":"2022-10-14","current":-6.585302,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":668269847},{"date":"2022-10-21","current":-6.532195,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":662880574},{"date":"2022-10-28","current":-6.631771,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":672985460},{"date":"2022-11-04","current":-6.611855,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":670964483},{"date":"2022-11-11","current":0.89271,"twenty":-6.146499,"median":-4.820655,"eighty":-3.940021,"marketCap":759213828},{"date":"2022-11-18","current":0.859441,"twenty":-6.127876,"median":-4.801195,"eighty":-3.931298,"marketCap":730920145},{"date":"2022-11-25","current":0.838193,"twenty":-6.120221,"median":-4.790159,"eighty":-3.924806,"marketCap":712849417},{"date":"2022-12-02","current":0.871404,"twenty":-6.112485,"median":-4.781893,"eighty":-3.907695,"marketCap":741094393},{"date":"2022-12-09","current":0.857961,"twenty":-6.085916,"median":-4.773739,"eighty":-3.868192,"marketCap":729661903},{"date":"2022-12-16","current":0.86745,"twenty":-6.066767,"median":-4.764624,"eighty":-3.84486,"marketCap":737731896},{"date":"2022-12-23","current":0.893545,"twenty":-6.05758,"median":-4.750843,"eighty":-3.819542,"marketCap":759924378},{"date":"2022-12-30","current":0.887219,"twenty":-6.047108,"median":-4.743423,"eighty":-3.802491,"marketCap":754544382},{"date":"2023-01-06","current":0.885638,"twenty":-6.047108,"median":-4.728054,"eighty":-3.791192,"marketCap":753199384},{"date":"2023-01-13","current":0.893545,"twenty":-6.047108,"median":-4.715093,"eighty":-3.772761,"marketCap":759924378},{"date":"2023-01-20","current":0.877335,"twenty":-6.047108,"median":-4.707156,"eighty":-3.760269,"marketCap":746138139},{"date":"2023-01-27","current":0.859543,"twenty":-6.044599,"median":-4.691483,"eighty":-3.742884,"marketCap":731006902},{"date":"2023-02-03","current":0.842147,"twenty":-6.044599,"median":-4.686259,"eighty":-3.723165,"marketCap":716211914},{"date":"2023-02-10","current":0.820796,"twenty":-6.044599,"median":-4.676099,"eighty":-3.710822,"marketCap":698054429},{"date":"2023-02-17","current":0.825541,"twenty":-6.044599,"median":-4.655962,"eighty":-3.702405,"marketCap":702089425},{"date":"2023-02-24","current":0.780468,"twenty":-6.044599,"median":-4.653259,"eighty":-3.691816,"marketCap":663756957},{"date":"2023-03-03","current":0.725859,"twenty":-6.044599,"median":-4.644464,"eighty":-3.673453,"marketCap":633045253},{"date":"2023-03-10","current":0.736672,"twenty":-6.044599,"median":-4.630524,"eighty":-3.653022,"marketCap":642474924},{"date":"2023-03-17","current":0.738834,"twenty":-6.044599,"median":-4.621402,"eighty":-3.638541,"marketCap":644360858},{"date":"2023-03-24","current":0.758296,"twenty":-6.044599,"median":-4.613117,"eighty":-3.627973,"marketCap":661334266},{"date":"2023-03-31","current":0.786576,"twenty":-6.04375,"median":-4.605891,"eighty":-3.615693,"marketCap":685997879},{"date":"2023-04-06","current":0.803975,"twenty":-6.04375,"median":-4.603005,"eighty":-3.605794,"marketCap":701172025},{"date":"2023-04-14","current":0.863421,"twenty":-6.044599,"median":-4.603005,"eighty":-3.587389,"marketCap":753017027},{"date":"2023-04-21","current":0.835873,"twenty":-6.044599,"median":-4.603005,"eighty":-3.563925,"marketCap":728991294},{"date":"2023-04-28","current":0.783676,"twenty":-6.044599,"median":-4.597235,"eighty":-3.536548,"marketCap":683468854},{"date":"2023-05-05","current":0.814849,"twenty":-6.044599,"median":-4.596353,"eighty":-3.51414,"marketCap":710655867},{"date":"2023-05-12","current":0.765928,"twenty":-6.044599,"median":-4.585694,"eighty":-3.495212,"marketCap":670945000},{"date":"2023-05-19","current":0.718518,"twenty":-6.044599,"median":-4.581354,"eighty":-3.485421,"marketCap":629414426},{"date":"2023-05-26","current":0.728415,"twenty":-6.044599,"median":-4.581354,"eighty":-3.453986,"marketCap":638084046},{"date":"2023-06-01","current":0.737652,"twenty":-6.044599,"median":-4.571181,"eighty":-3.439329,"marketCap":646175692},{"date":"2023-06-16","current":0.685528,"twenty":-6.047145,"median":-4.556078,"eighty":-3.259587,"marketCap":600515692},{"date":"2023-06-22","current":0.704002,"twenty":-6.047145,"median":-4.547581,"eighty":-3.182568,"marketCap":616698983},{"date":"2023-06-27","current":0.676291,"twenty":-6.047145,"median":-4.545402,"eighty":-3.136227,"marketCap":592424047},{"date":"2023-07-07","current":0.67761,"twenty":-6.047256,"median":-4.542588,"eighty":-3.012213,"marketCap":593579996},{"date":"2023-07-14","current":0.649899,"twenty":-6.047256,"median":-4.522012,"eighty":-2.971093,"marketCap":569305059},{"date":"2023-07-21","current":0.636703,"twenty":-6.047256,"median":-4.50904,"eighty":-2.924751,"marketCap":557745566},{"date":"2023-07-28","current":0.634724,"twenty":-6.047256,"median":-4.503406,"eighty":-2.867967,"marketCap":556011642},{"date":"2023-08-04","current":0.654518,"twenty":-6.047256,"median":-4.48687,"eighty":-2.794864,"marketCap":573350882},{"date":"2023-08-11","current":0.609287,"twenty":-6.045447,"median":-4.479345,"eighty":-2.74787,"marketCap":529187302},{"date":"2023-08-18","current":0.585572,"twenty":-6.045447,"median":-4.462624,"eighty":-2.728289,"marketCap":508590191},{"date":"2023-08-25","current":0.575235,"twenty":-6.045447,"median":-4.449502,"eighty":-2.674115,"marketCap":499611963},{"date":"2023-09-01","current":0.578883,"twenty":-6.033007,"median":-4.428611,"eighty":-2.593833,"marketCap":502780750},{"date":"2023-09-08","current":0.589828,"twenty":-6.016567,"median":-4.420338,"eighty":-2.539658,"marketCap":512287108},{"date":"2023-09-15","current":0.590436,"twenty":-5.994874,"median":-4.403007,"eighty":-2.392444,"marketCap":512815239},{"date":"2023-09-22","current":0.547871,"twenty":-5.980167,"median":-4.390072,"eighty":-2.342937,"marketCap":475846067},{"date":"2023-09-29","current":0.509563,"twenty":-5.971921,"median":-4.382328,"eighty":-2.283974,"marketCap":442573811},{"date":"2023-10-06","current":0.550912,"twenty":-5.945804,"median":-4.367183,"eighty":-2.22223,"marketCap":478486722},{"date":"2023-10-13","current":0.558209,"twenty":-5.937293,"median":-4.348344,"eighty":-2.190524,"marketCap":484824294},{"date":"2023-10-20","current":0.545439,"twenty":-5.919911,"median":-4.338527,"eighty":-2.170498,"marketCap":473733542},{"date":"2023-10-27","current":0.561857,"twenty":-5.91888,"median":-4.325904,"eighty":-2.158261,"marketCap":487993080},{"date":"2023-11-03","current":0.594693,"twenty":-5.91888,"median":-4.301844,"eighty":-2.068148,"marketCap":516512157},{"date":"2023-11-10","current":-8.790683,"twenty":-5.931389,"median":-4.294914,"eighty":-2.058135,"marketCap":501464510},{"date":"2023-11-17","current":-8.982734,"twenty":-5.941785,"median":-4.294914,"eighty":-2.058135,"marketCap":512420041},{"date":"2023-11-24","current":-9.139866,"twenty":-5.951889,"median":-4.294914,"eighty":-2.058135,"marketCap":521383657},{"date":"2023-12-01","current":-9.148596,"twenty":-5.974498,"median":-4.294914,"eighty":-2.058135,"marketCap":521881635},{"date":"2023-12-08","current":-9.25335,"twenty":-5.976931,"median":-4.29496,"eighty":-2.058135,"marketCap":527857379},{"date":"2023-12-15","current":-9.611263,"twenty":-5.982249,"median":-4.29496,"eighty":-2.058135,"marketCap":548274504},{"date":"2023-12-22","current":-9.89061,"twenty":-6.037727,"median":-4.29496,"eighty":-2.058135,"marketCap":564209821},{"date":"2023-12-29","current":-9.87315,"twenty":-6.055696,"median":-4.294914,"eighty":-2.058135,"marketCap":563213864},{"date":"2024-01-05","current":-10.056471,"twenty":-6.065646,"median":-4.293344,"eighty":-2.058135,"marketCap":573671416},{"date":"2024-01-12","current":-8.537525,"twenty":-6.075519,"median":-4.293344,"eighty":-2.058135,"marketCap":487023129},{"date":"2024-01-19","current":-8.310556,"twenty":-6.115014,"median":-4.291775,"eighty":-2.058135,"marketCap":474075684},{"date":"2024-01-26","current":-8.65101,"twenty":-6.124513,"median":-4.293344,"eighty":-2.058135,"marketCap":493496852},{"date":"2024-02-02","current":-7.996292,"twenty":-6.153311,"median":-4.293344,"eighty":-2.058135,"marketCap":456148452},{"date":"2024-02-09","current":-7.175711,"twenty":-6.191017,"median":-4.293344,"eighty":-2.058135,"marketCap":409338458},{"date":"2024-02-16","current":-7.568542,"twenty":-6.210395,"median":-4.293344,"eighty":-2.058135,"marketCap":431747498},{"date":"2024-02-23","current":-7.572907,"twenty":-6.222321,"median":-4.293344,"eighty":-2.058135,"marketCap":431996487},{"date":"2024-03-01","current":-8.252985,"twenty":-6.244375,"median":-4.294914,"eighty":-2.058135,"marketCap":455507000},{"date":"2024-03-08","current":-7.583413,"twenty":-6.26237,"median":-4.294914,"eighty":-2.058135,"marketCap":418551312},{"date":"2024-03-15","current":-7.5136,"twenty":-6.300389,"median":-4.294914,"eighty":-2.058135,"marketCap":414698135},{"date":"2024-03-22","current":-7.819031,"twenty":-6.378281,"median":-4.294914,"eighty":-2.058135,"marketCap":431555783},{"date":"2024-03-28","current":-7.862664,"twenty":-6.418847,"median":-4.294914,"eighty":-2.058135,"marketCap":433964019},{"date":"2024-04-05","current":-7.97611,"twenty":-6.461522,"median":-4.293344,"eighty":-2.058135,"marketCap":440225431},{"date":"2024-04-12","current":-7.856801,"twenty":-6.51133,"median":-4.293344,"eighty":-2.058135,"marketCap":433640398},{"date":"2024-04-19","current":-8.094352,"twenty":-6.533511,"median":-4.293344,"eighty":-2.058135,"marketCap":446751586},{"date":"2024-04-26","current":-8.041563,"twenty":-6.555878,"median":-4.294914,"eighty":-2.058135,"marketCap":443837988},{"date":"2024-05-03","current":-8.243922,"twenty":-6.57917,"median":-4.294914,"eighty":-2.058135,"marketCap":455006778},{"date":"2024-05-10","current":-8.331904,"twenty":-6.603902,"median":-4.294914,"eighty":-2.058135,"marketCap":459862773},{"date":"2024-05-17","current":-10.428621,"twenty":-6.620365,"median":-4.294914,"eighty":-2.058135,"marketCap":466878950},{"date":"2024-05-24","current":-9.287991,"twenty":-6.638909,"median":-4.294914,"eighty":-2.058135,"marketCap":415814065},{"date":"2024-05-31","current":-9.364033,"twenty":-6.650555,"median":-4.295005,"eighty":-2.058135,"marketCap":419218390},{"date":"2024-06-07","current":-9.52698,"twenty":-6.694809,"median":-4.325904,"eighty":-2.058135,"marketCap":426513374},{"date":"2024-06-14","current":-9.211949,"twenty":-6.71825,"median":-4.341766,"eighty":-2.058135,"marketCap":412409739},{"date":"2024-06-21","current":-9.505254,"twenty":-6.734002,"median":-4.355322,"eighty":-2.058135,"marketCap":425540710},{"date":"2024-06-28","current":-9.211949,"twenty":-6.779224,"median":-4.372866,"eighty":-2.058135,"marketCap":412409739},{"date":"2024-07-05","current":-9.516117,"twenty":-6.797179,"median":-4.380229,"eighty":-2.058135,"marketCap":426027042},{"date":"2024-07-12","current":-10.178769,"twenty":-6.830716,"median":-4.388518,"eighty":-2.058135,"marketCap":455693308},{"date":"2024-07-19","current":-10.396032,"twenty":-6.872973,"median":-4.390072,"eighty":-2.058135,"marketCap":465419953},{"date":"2024-07-26","current":-11.134726,"twenty":-6.891461,"median":-4.390072,"eighty":-2.058135,"marketCap":498490546},{"date":"2024-08-02","current":-10.472074,"twenty":-6.923329,"median":-4.390072,"eighty":-2.058135,"marketCap":468824279},{"date":"2024-08-09","current":-8.208511,"twenty":-6.991855,"median":-4.390072,"eighty":-2.058135,"marketCap":374743155},{"date":"2024-08-16","current":-8.722883,"twenty":-7.040293,"median":-4.390072,"eighty":-2.058135,"marketCap":398225755},{"date":"2024-08-23","current":-8.669302,"twenty":-7.071924,"median":-4.390072,"eighty":-2.058135,"marketCap":395779651},{"date":"2024-08-30","current":-8.840759,"twenty":-7.095683,"median":-4.390072,"eighty":-2.058135,"marketCap":403607184},{"date":"2024-09-06","current":-8.583574,"twenty":-7.124878,"median":-4.390072,"eighty":-2.058135,"marketCap":391865884},{"date":"2024-09-13","current":-8.722883,"twenty":-7.15789,"median":-4.390072,"eighty":-2.058135,"marketCap":398225755},{"date":"2024-09-20","current":-8.583574,"twenty":-7.176311,"median":-4.390072,"eighty":-2.058135,"marketCap":391865884},{"date":"2024-09-27","current":-8.680018,"twenty":-7.267005,"median":-4.390072,"eighty":-2.058135,"marketCap":396268872},{"date":"2024-10-04","current":-8.680018,"twenty":-7.321396,"median":-4.390072,"eighty":-2.058135,"marketCap":396268872},{"date":"2024-10-11","current":-8.905056,"twenty":-7.414557,"median":-4.390072,"eighty":-2.058135,"marketCap":406542509},{"date":"2024-10-18","current":-9.430143,"twenty":-7.483207,"median":-4.403007,"eighty":-2.058135,"marketCap":430514330},{"date":"2024-10-25","current":-9.162241,"twenty":-7.522918,"median":-4.428094,"eighty":-2.058135,"marketCap":418283809},{"date":"2024-11-01","current":-8.872908,"twenty":-7.555488,"median":-4.449502,"eighty":-2.058135,"marketCap":405074847},{"date":"2024-11-08","current":-9.580168,"twenty":-7.58367,"median":-4.462624,"eighty":-2.058135,"marketCap":437363422},{"date":"2024-11-15","current":-9.476312,"twenty":-7.660028,"median":-4.470012,"eighty":-2.058135,"marketCap":468139297},{"date":"2024-11-22","current":-9.426542,"twenty":-7.698009,"median":-4.473891,"eighty":-2.058135,"marketCap":465680583},{"date":"2024-11-29","current":-9.207551,"twenty":-7.724093,"median":-4.473891,"eighty":-2.058135,"marketCap":454862238},{"date":"2024-12-06","current":-9.83466,"twenty":-7.785188,"median":-4.473891,"eighty":-2.058135,"marketCap":485842044},{"date":"2024-12-13","current":-9.83466,"twenty":-7.85453,"median":-4.473891,"eighty":-2.058135,"marketCap":485842044},{"date":"2024-12-20","current":-9.545991,"twenty":-7.888793,"median":-4.473891,"eighty":-2.058135,"marketCap":471581498},{"date":"2024-12-27","current":-9.545991,"twenty":-7.955166,"median":-4.473891,"eighty":-2.058135,"marketCap":471581498},{"date":"2025-01-03","current":-9.267276,"twenty":-8.026643,"median":-4.473891,"eighty":-2.058135,"marketCap":457812695},{"date":"2025-01-10","current":-8.739708,"twenty":-8.06796,"median":-4.472059,"eighty":-2.058135,"marketCap":431750318},{"date":"2025-01-17","current":-8.540626,"twenty":-8.156953,"median":-4.472059,"eighty":-2.058135,"marketCap":421915459},{"date":"2025-01-24","current":-10.421953,"twenty":-8.213921,"median":-4.472059,"eighty":-2.058135,"marketCap":514854879},{"date":"2025-01-31","current":-9.336955,"twenty":-8.252879,"median":-4.472059,"eighty":-2.058135,"marketCap":461254896},{"date":"2025-02-07","current":-9.257322,"twenty":-8.323106,"median":-4.472059,"eighty":-2.058135,"marketCap":457320952},{"date":"2025-02-14","current":-9.565899,"twenty":-8.341142,"median":-4.472059,"eighty":-2.058135,"marketCap":472564984},{"date":"2025-02-21","current":-9.272253,"twenty":-8.393491,"median":-4.472059,"eighty":-2.058135,"marketCap":458058567},{"date":"2025-02-28","current":-8.203499,"twenty":-8.404456,"median":-4.472059,"eighty":-2.058135,"marketCap":462825000},{"date":"2025-03-07","current":-8.356469,"twenty":-8.442324,"median":-4.470012,"eighty":-2.058135,"marketCap":471455265},{"date":"2025-03-14","current":-8.093411,"twenty":-8.442324,"median":-4.470012,"eighty":-2.058135,"marketCap":456614071},{"date":"2025-03-21","current":-8.233709,"twenty":-8.442324,"median":-4.470012,"eighty":-2.058135,"marketCap":464529375},{"date":"2025-03-28","current":-8.093411,"twenty":-8.442324,"median":-4.470012,"eighty":-2.058135,"marketCap":456614071},{"date":"2025-04-04","current":-7.400692,"twenty":-8.442324,"median":-4.470012,"eighty":-2.058135,"marketCap":417532260},{"date":"2025-04-11","current":-7.444631,"twenty":-8.439935,"median":-4.472059,"eighty":-2.058135,"marketCap":420011188},{"date":"2025-04-17","current":-7.639609,"twenty":-8.439935,"median":-4.472059,"eighty":-2.058135,"marketCap":431011481},{"date":"2025-04-25","current":-8.641089,"twenty":-8.453235,"median":-4.470012,"eighty":-2.058135,"marketCap":487512987},{"date":"2025-05-02","current":-9.190574,"twenty":-8.506418,"median":-4.470012,"eighty":-2.058135,"marketCap":518513812},{"date":"2025-05-09","current":-7.697392,"twenty":-8.524385,"median":-4.470012,"eighty":-2.058135,"marketCap":449011961},{"date":"2025-05-16","current":-7.885969,"twenty":-8.524385,"median":-4.470012,"eighty":-2.058135,"marketCap":460012254},{"date":"2025-05-23","current":-8.134549,"twenty":-8.524385,"median":-4.470012,"eighty":-2.058135,"marketCap":474512640},{"date":"2025-05-30","current":-7.971686,"twenty":-8.524385,"median":-4.470012,"eighty":-2.058135,"marketCap":465012387},{"date":"2025-06-06","current":-9.231727,"twenty":-8.530536,"median":-4.470012,"eighty":-2.058135,"marketCap":538514345},{"date":"2025-06-13","current":-9.09458,"twenty":-8.572384,"median":-4.470012,"eighty":-2.058135,"marketCap":530514132},{"date":"2025-06-20","current":-9.103152,"twenty":-8.583574,"median":-4.467966,"eighty":-2.058135,"marketCap":531014145},{"date":"2025-06-27","current":-9.19744,"twenty":-8.626438,"median":-4.467966,"eighty":-2.058135,"marketCap":536514292},{"date":"2025-07-03","current":-9.557452,"twenty":-8.637154,"median":-4.467966,"eighty":-2.058135,"marketCap":557514851},{"date":"2025-07-11","current":-9.823175,"twenty":-8.658815,"median":-4.467966,"eighty":-2.058135,"marketCap":573015264},{"date":"2025-07-18","current":-9.960322,"twenty":-8.680018,"median":-4.467966,"eighty":-2.058135,"marketCap":581015477},{"date":"2025-07-25","current":-9.540309,"twenty":-8.722883,"median":-4.467966,"eighty":-2.058135,"marketCap":556514825},{"date":"2025-08-01","current":-9.566024,"twenty":-8.744315,"median":-4.467966,"eighty":-2.058135,"marketCap":558014865},{"date":"2025-08-08","current":-9.608882,"twenty":-8.773224,"median":-4.472059,"eighty":-2.058135,"marketCap":560514931},{"date":"2025-08-15","current":50.009606,"twenty":-8.797895,"median":-4.479693,"eighty":-1.977479,"marketCap":651675170},{"date":"2025-08-22","current":52.792211,"twenty":-8.797895,"median":-4.479693,"eighty":-1.907947,"marketCap":687935303},{"date":"2025-08-29","current":53.990277,"twenty":-8.797895,"median":-4.479693,"eighty":0.527805,"marketCap":703547305},{"date":"2025-09-05","current":54.299456,"twenty":-8.797895,"median":-4.481101,"eighty":0.545682,"marketCap":707576208},{"date":"2025-09-12","current":52.9468,"twenty":-8.797895,"median":-4.479693,"eighty":0.549088,"marketCap":689949755},{"date":"2025-09-19","current":55.922642,"twenty":-8.797895,"median":-4.479693,"eighty":0.550912,"marketCap":728727953},{"date":"2025-09-26","current":53.294626,"twenty":-8.797895,"median":-4.479693,"eighty":0.558209,"marketCap":694482271},{"date":"2025-10-03","current":54.37675,"twenty":-8.797895,"median":-4.479693,"eighty":0.56733,"marketCap":708583434},{"date":"2025-10-10","current":56.077232,"twenty":-8.797895,"median":-4.479693,"eighty":0.575235,"marketCap":730742404},{"date":"2025-10-17","current":54.260808,"twenty":-8.797895,"median":-4.475724,"eighty":0.582531,"marketCap":707072595},{"date":"2025-10-24","current":54.647281,"twenty":-8.797895,"median":-4.467966,"eighty":0.590436,"marketCap":712108725},{"date":"2025-10-31","current":55.265638,"twenty":-8.797895,"median":-4.449502,"eighty":0.596517,"marketCap":720166532},{"date":"2025-11-07","current":57.468534,"twenty":-8.797895,"median":-4.428611,"eighty":0.600774,"marketCap":748872471},{"date":"2025-11-14","current":30.996801,"twenty":-8.797895,"median":-4.428611,"eighty":0.609287,"marketCap":909570136},{"date":"2025-11-21","current":30.910459,"twenty":-8.797895,"median":-4.428611,"eighty":0.629445,"marketCap":907036514},{"date":"2025-11-28","current":35.054878,"twenty":-8.797895,"median":-4.428611,"eighty":0.636043,"marketCap":1028650349},{"date":"2025-12-05","current":32.291932,"twenty":-8.797895,"median":-4.428611,"eighty":0.640002,"marketCap":947574459},{"date":"2025-12-12","current":30.530554,"twenty":-8.797895,"median":-4.428611,"eighty":0.652538,"marketCap":895888580},{"date":"2025-12-16","current":30.68597,"twenty":-8.797895,"median":-4.410663,"eighty":0.654518,"marketCap":900449098}],"updateTime":1766011892598},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582800897","title":"BRIEF-Theravance Biopharma Q3 Operating Income USD -6.455 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800897","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800897?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808747,"startTime":"0","endTime":"0","summary":"BRIEF-Theravance Biopharma Q3 Operating Income USD -6.455 Million\n\n\nNov 10 (Reuters) - Theravance Biopharma Q3 revenue USD 19.99 million vs. IBES estimate USD 19.3 million.\n\nQ3 net income USD 3.615 million\nQ3 adjusted net income USD 2.26 million vs. IBES estimate USD -6.76 million\nQ3 EPS USD 0.07","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXFC0A7D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2582077638","title":"Theravance Biopharma Q3 EPS USD 0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2582077638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582077638?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXFC0A7D:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2582827907","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2582827907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582827907?lang=en_us&edition=fundamental","pubTime":"2025-11-10 19:00","pubTimestamp":1762772400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Barrick Mining Corp                                3Q       .60   6:00 AM. ·Belite Bio Inc. ADR                             3Q      (.49)      AMC. ·Blckstne Sec Ldg                                3Q       .78   6:50 AM. ·DHI Grp Inc.                                     3Q       .04   4:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d36bfa730d18775aec9ad51d0643309e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHGG","APEI","CEVA","CAMT","DHX","BAK","ACDC","AIOT","ADCT","DCGO","BCSF","DOX","BLTE","AU","DDI","AII","AMBC","BDTX","CAPR","BODI","ALEC","OSG","BKV","DSP","ANTA","B","ARCT","BEKE","DOLE","BTDR","CNTY","CART","OXY","AGEN","BEEP","MNDY","BALY","BXSL","BARK","TBPH","AKBA","ONTF","BW","CGEN","ASRT","AOMR"],"gpt_icon":1},{"id":"2582817343","title":"Theravance Biopharma (TBPH) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2582817343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582817343?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:16","pubTimestamp":1762737386,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Theravance Biopharma, with a price target of $15.00. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/theravance-biopharma-tbph-gets-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/theravance-biopharma-tbph-gets-a-buy-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2579975845","title":"Theravance Biopharma Announces Phase 3 CYPRESS Study Results for Ampreloxetine Expected in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2579975845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579975845?lang=en_us&edition=fundamental","pubTime":"2025-10-29 18:00","pubTimestamp":1761732053,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc. has announced its participation in the 36th International Symposium on the Autonomic Nervous System, scheduled for November 5-8, 2025. The company will present new data from its clinical development program for ampreloxetine, a norepinephrine reuptake inhibitor under investigation for the treatment of symptomatic neurogenic orthostatic hypotension  associated with multiple system atrophy . The presentations will include one platform session highlighting results from the previous REDWOOD trial, which observed a durable symptomatic benefit in a pre-specified subgroup of MSA patients treated with ampreloxetine. Additionally, three poster presentations will detail methodologies supporting enrollment and retention in rare disease clinical trials. Topline results from the ongoing Phase 3 CYPRESS study of ampreloxetine are anticipated in the first quarter of 2026 and have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL4gGJty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2575905745","title":"Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2575905745","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575905745?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA8BV5MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2575575295","title":"Theravance Biopharma Presents New Data Showing YUPELRI® Reduces COPD Exacerbations and Healthcare Costs at CHEST 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575575295","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575575295?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:01","pubTimestamp":1760436118,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc. announced that it will present new analyses related to YUPELRI  at the upcoming CHEST 2025 Annual Meeting, scheduled for October 19-22, 2025, in Chicago, IL. The company will deliver two rapid-fire presentations on October 21, 2025. One presentation will cover a retrospective cohort study of claims data, which found that COPD patients adherent to YUPELRI following hospital discharge experienced significantly fewer and less severe exacerbations, as well as lower healthcare costs, compared to non-adherent patients. Another presentation will share post-hoc analyses of a Phase 3 safety study, showing that patients taking YUPELRI had a significantly lower incidence of moderate-to-severe acute exacerbations and overall less severe exacerbations compared to those taking tiotropium. These results will be presented at the CHEST 2025 Annual Meeting and have not yet been presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDLbByx7M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2566397505","title":"B. Riley Initiates Theravance Biopharma at Buy With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2566397505","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566397505?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:20","pubTimestamp":1757676052,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (TBPH) has an average rating of overweight and mean price target of $20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RILY","TBPH"],"gpt_icon":0},{"id":"2566922999","title":"Theravance Biopharma initiated with a Buy at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2566922999","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566922999?lang=en_us&edition=fundamental","pubTime":"2025-09-12 16:50","pubTimestamp":1757667015,"startTime":"0","endTime":"0","summary":"B. Riley analyst Mayank Mamtani initiated coverage of Theravance Biopharma (TBPH) with a Buy rating and $28 price target The firm says Theravanc is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-initiated-with-a-buy-at-b-riley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-initiated-with-a-buy-at-b-riley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B66KJ199.SGD","RILY","BK4007","TBPH","BK4127","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD"],"gpt_icon":0},{"id":"2566944807","title":"Theravance Biopharma Inc : B. Riley Initiates Coverage With Buy Rating; Price Target $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2566944807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566944807?lang=en_us&edition=fundamental","pubTime":"2025-09-12 10:59","pubTimestamp":1757645980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UZ000:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2564803125","title":"Theravance Biopharma Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803125","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564803125?lang=en_us&edition=fundamental","pubTime":"2025-09-02 18:01","pubTimestamp":1756807269,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc. will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York City. CEO Rick Winningham is set to engage in a Fireside Chat on Tuesday, September 9, 2025, at 1:30 PM EDT. The company's management will also conduct in-person meetings during the event, and a live webcast will be available for interested parties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via PR Newswire  on September 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL4HtKkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2562210916","title":"Theravance Biopharma Completes Enrollment in Phase 3 CYPRESS Study for Ampreloxetine in Treating Neurogenic Orthostatic Hypotension Due to MSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2562210916","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562210916?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:00","pubTimestamp":1756116025,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Completes Enrollment in Phase 3 CYPRESS Study for Ampreloxetine in Treating Neurogenic Orthostatic Hypotension Due to MSA. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via PR Newswire  on August 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL1lfm6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2562210178","title":"Theravance Biopharma Completes Enrollment in Pivotal Phase 3 Cypress Study of Ampreloxetine in Patients With Symptomatic Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2562210178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562210178?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:00","pubTimestamp":1756116011,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2562210101","title":"Theravance: Topline Results Anticipated in Q1 2026 and, IF Successful, Planning for Expedited Nda Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2562210101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562210101?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:00","pubTimestamp":1756116011,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH019:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2560103798","title":"BRIEF-Theravance Biopharma Inc - Co And Mylan Settle With Cipla Over Yupelri Inhalation Solution - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2560103798","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560103798?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:15","pubTimestamp":1755692150,"startTime":"0","endTime":"0","summary":"BRIEF-Theravance Biopharma Inc - Co And Mylan Settle With Cipla Over Yupelri Inhalation Solution - SEC FilingTheravance Biopharma Inc TBPH.O:THERAVANCE BIOPHARMA INC - CO AND MYLAN SETTLE WITH CIPLA OVER YUPELRI INHALATION SOLUTION - SEC FILINGTHERAVANCE BIOPHARMA- CO, MYLAN GRANTED CIPLA LICENSE TO MANUFACTURE & MARKET GENERIC VERSION OF YUPELRI IN US ON/AFTER APRIL 23, 2039Source text: [ID:n0001104659-25-080470]Further company coverage: TBPH.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC01R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2560770171","title":"Theravance Biopharma- Co, Mylan Granted Cipla License to Manufacture & Market Generic Version of Yupelri in US on/After April 23, 2039","url":"https://stock-news.laohu8.com/highlight/detail?id=2560770171","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560770171?lang=en_us&edition=fundamental","pubTime":"2025-08-20 18:07","pubTimestamp":1755684446,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC01R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2560171743","title":"Theravance Biopharma Inc. Reaches Settlement with Cipla Over YUPELRI® Patent Dispute, Granting Future License for Generic Version","url":"https://stock-news.laohu8.com/highlight/detail?id=2560171743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560171743?lang=en_us&edition=fundamental","pubTime":"2025-08-20 18:06","pubTimestamp":1755684377,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc. Reaches Settlement with Cipla Over YUPELRI Patent Dispute, Granting Future License for Generic Version. Theravance Biopharma Inc. has reached a Settlement Agreement with Cipla Limited and Cipla USA, Inc. regarding the ongoing patent litigation over YUPELRI  inhalation solution. This settlement allows Cipla to manufacture and market a generic version of the drug in the United States starting from April 23, 2039, under a royalty-free, non-exclusive license. The resolution follows Cipla's filing of an abbreviated new drug application  to market a generic version before the expiration of several patents held by Theravance and Mylan. The agreement is pending review by the U.S. Department of Justice and the Federal Trade Commission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL3NPm2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"1149483890","title":"Stock Track | Theravance Biopharma Soars 5.58% on Analyst Upgrades and Bullish Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1149483890","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149483890?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:32","pubTimestamp":1755091964,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (TBPH) shares are soaring 5.58% in pre-market trading on Wednesday, as investors react positively to recent analyst actions. The biopharmaceutical company's stock is gaining...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TBPH"],"gpt_icon":0},{"id":"2559962183","title":"Theravance Biopharma Q2 Adj. EPS $(0.08) Beats $(0.17) Estimate, Sales $26.195M Beat $22.437M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559962183","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559962183?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:10","pubTimestamp":1755029432,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.17) by 52.94 percent. This is a 38.46 percent increase over losses of $(0.13) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47074191/theravance-biopharma-q2-adj-eps-0-08-beats-0-17-estimate-sales-26-195m-beat-22-437m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Theravance Biopharma Q2 Adj. EPS $(0.08) Beats $(0.17) Estimate, Sales $26.195M Beat $22.437M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2559762186","title":"Theravance Biopharma Reports 31% Increase in Viatris Collaboration Revenue for Q2 2025; YUPELRI Net Sales Rise 22% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2559762186","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559762186?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:07","pubTimestamp":1755029249,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Reports 31% Increase in Viatris Collaboration Revenue for Q2 2025; YUPELRI Net Sales Rise 22% Year-over-Year. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via PR Newswire  on August 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL417zxr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","TBPH"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}]}}